Ann Lab Med.  2019 Sep;39(5):447-453. 10.3343/alm.2019.39.5.447.

Use of Liquid Chromatography-Tandem Mass Spectrometry for Clinical Testing in Korean Laboratories: a Questionnaire Survey

Affiliations
  • 1Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • 2LabGenomics Clinical Laboratories, Seongnam, Korea.
  • 3Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. suddenbz@skku.edu
  • 4Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea.
  • 5Department of Laboratory Medicine and Genetics, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea.
  • 6Department of Laboratory Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea.
  • 7Department of Laboratory Medicine, Seoul National University Hospital and College of Medicine, Seoul, Korea.
  • 8Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • 9Department of Laboratory Medicine, Seoul National University Bundang Hospital and College of Medicine, Seongnam, Korea.

Abstract

BACKGROUND
The use of liquid chromatography-tandem mass spectrometry (LC-MS/MS) has substantially increased in clinical laboratories worldwide. To assess the status of clinical LC-MS/MS testing in Korean laboratories, a questionnaire survey was performed by the Clinical Mass Spectrometry Research Committee of the Korean Society of Clinical Chemistry.
METHODS
The questionnaire was distributed to 19 clinical laboratories performing clinical LC-MS/MS from April to May 2018. It asked about general characteristics of the laboratory and commonly utilized clinical LC-MS/MS tests: newborn screening, tacrolimus test, vitamin D test, and plasma metanephrine test. Frequency analysis and other statistical analyses were performed.
RESULTS
A total of 17 laboratories responded. The median number of LC-MS/MS instruments, laboratory medicine physicians, and technicians in each laboratory was three, one, and two, respectively. Nine laboratory directors had >10 years of experience with clinical LC-MS/MS. For each LC-MS/MS test, at least two concentrations of QC materials were measured every 24 hours during clinical testing, and all laboratories used QC acceptability criteria based on their established QC means and SDs. All laboratories participated in an external quality assessment program. However, there was inter-laboratory variability in sample preparation methods, instruments, reagents, internal standards, and calibrators.
CONCLUSIONS
LC-MS/MS has been successfully introduced in Korean clinical laboratories and is used within a quality framework. Further efforts for harmonization on a nationwide basis could facilitate the widespread use of LC-MS/MS.

Keyword

Liquid chromatography-tandem mass spectrometry; Korea; Survey; Harmonization

MeSH Terms

Chemistry, Clinical
Humans
Indicators and Reagents
Infant, Newborn
Korea
Mass Screening
Mass Spectrometry*
Metanephrine
Plasma
Tacrolimus
Vitamin D
Indicators and Reagents
Metanephrine
Tacrolimus
Vitamin D

Cited by  4 articles

Immunosuppressive Drug Measurement by Liquid Chromatography Coupled to Tandem Mass Spectrometry: Interlaboratory Comparison in the Korean Clinical Laboratories
Hyun-Ki Kim, Hyung-Doo Park, Sang-Guk Lee, Hyojin Chae, Sang Hoon Song, Yong-Wha Lee, Yeo-Min Yun, Sunhyun Ahn, Serim Kim, Sun Min Lee, Soo-Youn Lee, Sail Chun
Ann Lab Med. 2021;41(3):268-276.    doi: 10.3343/alm.2021.41.3.268.

Recommendations for the Use of Liquid Chromatography-Mass Spectrometry in the Clinical Laboratory: Part I. Implementation and Management
Kyunghoon Lee, Soo Young Moon, Serim Kim, Hyun-Jung Choi, Sang-Guk Lee, Hyung-Doo Park, Soo-Youn Lee, Sang Hoon Song,
Lab Med Online. 2020;10(1):1-9.    doi: 10.3343/lmo.2020.10.1.1.

Back to the Basics of Liquid Chromatography-Mass Spectrometry
Young Jin Kim, Soo-Youn Lee, Mina Hur
Ann Lab Med. 2022;42(2):119-120.    doi: 10.3343/alm.2022.42.2.119.

Comprehensive Evaluation of the NeoBase 2 Non-derivatized MSMS Assay and Exploration of Analytes With Significantly Different Concentrations Between Term and Preterm Neonates
Beomki Lee, Won Young Heo, Jee Ah Kim, Hyun-Seung Lee, Narae Hwang, Hyung-Doo Park, Se In Sung, Yun Sil Chang, Won Soon Park, Soo-Youn Lee
Ann Lab Med. 2023;43(2):153-166.    doi: 10.3343/alm.2023.43.2.153.


Reference

1. Taylor PJ. High-performance liquid chromatography-mass spectrometry in the clinical laboratory. Ther Drug Monit. 2005; 27:689–693. PMID: 16404795.
2. Dooley KC. Tandem mass spectrometry in the clinical chemistry laboratory. Clin Biochem. 2003; 36:471–481. PMID: 12951172.
3. Grebe SK, Singh RJ. LC-MS/MS in the clinical laboratory–where to from here? Clin Biochem Rev. 2011; 32:5–31. PMID: 21451775.
4. Shin BM, Chae SL, Min WK, Lee WG, Lim YA, Lee DH, et al. The implementation and effects of a clinical laboratory accreditation program in Korea from 1999 to 2006. Korean J Lab Med. 2009; 29:163–170. PMID: 19411785.
5. Greaves RF. Recent advances in the clinical application of mass spectrometry. EJIFCC. 2016; 27:264–271. PMID: 28149261.
6. CDC. Newborn Screening Quality Assurance Program 2018 Quailty Control Report. Issued June 8, 2018. https://www.cdc.gov/labstandards/pdf/nsqap/nsqap_2018_qcset1_report.pdf.
7. Al-Jenoobi FI, Alam MA, Al-Mohizea AM. Quantification of immunosuppressant's in blood using LC-MS/MS. Austin Chromatogr. 2016; 3:1039.
8. Couchman L, Benton CM, Moniz CF. Variability in the analysis of 25-hydroxyvitamin D by liquid chromatography-tandem mass spectrometry: the devil is in the detail. Clin Chim Acta. 2012; 413:1239–1243. PMID: 22515958.
9. Marney LC, Laha TJ, Baird GS, Rainey PM, Hoofnagle AN. Isopropanol protein precipitation for the analysis of plasma free metanephrines by liquid chromatography-tandem mass spectrometry. Clin Chem. 2008; 54:1729–1732. PMID: 18687739.
10. CLSI. Liquid chromatography-mass spectrometry methods; approved guideline. CLSI C62-A. Wayne, PA: Clinical and Laboratory Standards Institute;2014.
11. Valbuena H, Shipkova M, Kliesch SM, Müller S, Wieland E. Comparing the effect of isotopically labeled or structural analog internal standards on the performance of a LC-MS/MS method to determine ciclosporin A, everolimus, sirolimus and tacrolimus in whole blood. Clin Chem Lab Med. 2016; 54:437–446. PMID: 26351941.
12. Buchwald A, Winkler K, Epting T. Validation of an LC-MS/MS method to determine five immunosuppressants with deuterated internal standards including MPA. BMC Clin Pharmacol. 2012; 12:2. PMID: 22236286.
13. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Veterinary Medicine. Guidance for industry: bioanalytical method validation. Updated on May 2018. https://www.fda.gov/downloads/drugs/guidances/ucm070107.pdf.
14. European Medicines Agency. Guideline on bioanalytical method validation. Updated on July 2011. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500109686.pdf.
15. Scientific Working Group for Forensic Toxicology. Scientific Working Group for Forensic Toxicology (SWGTOX) standard practices for method validation in forensic toxicology. J Anal Toxicol. 2013; 37:452–474. PMID: 23934984.
Full Text Links
  • ALM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr